CHUC
Charlie's Holdings, Inc.0.1830
+0.0067+3.8%
Dec 16, 4:00:00 PM EST
Earnings Call Transcripts
This Quarter (Q1 '26)
No earnings call transcript available yet
Last Quarter (Q4 '25)
No earnings call transcript available
Key Stats
Market Cap
49.53MP/E (TTM)
18.30Basic EPS (TTM)
0.01Dividend Yield
0%Recent Filings
8-K
Sold 3.55M shares at $0.20
Charlie's Holdings sold 3,550,000 common shares at $0.20 each on February 13, 2026, raising $710,000 total—$510,000 cash plus $200,000 debt forgiveness—for working capital and PMTA amendments. Private placement to accredited investors under Section 4(a)(2). Investors acknowledge going concern doubts.
10-Q
Q3 FY2025 results
Charlie's Holdings turned profitable in Q3 ended September 30, 2025, with product revenue jumping 336% y/y to $7.1M on SBX non-nicotine vape strength, though gross margin slipped to 24.9% from 38.8% as third-party sales diluted mix. Operating loss narrowed to $339K from $876K y/y, but net swung to $624K profit thanks to $1.0M gain on PMTA asset sales to R.J. Reynolds (closed April/May/August 2025 for $7.5M total). Cash climbed to $1.2M with $3.1M working capital; related-party notes payable hit $2.5M due 2026. YTD diluted EPS $0.02 reconciles to 276M shares. FDA MDOs on certain PMTAs pose regulatory risk.
10-Q
Q2 FY2025 results
Charlie's Holdings swung to profitability in Q2 FY2025 ended June 30, 2025, posting net income of $4.961M on $2.544M revenue, up 24.5% y/y from $2.043M, while YTD revenue dipped 4.8% y/y to $4.850M but net income hit $3.744M versus a $2.012M loss last year. Operating loss widened slightly to $877K from $736K y/y amid higher COGS at 73.9% of revenue, yet a $6.5M gain from selling PMTA assets to R.J. Reynolds Vapor Company in April-May 2025 for cash turned the tide, alongside $99K debt extinguishment gain; taxes took $426K. Cash climbed to $1.453M with $2.211M working capital, total debt at $825K maturing mostly in 2026, and free cash flow not disclosed in the 10-Q. The asset sale closed for $6.5M cash plus up to $4.2M contingent, recognizing no goodwill. Diluted EPS of $0.02 reconciles to 281.98M shares with no anti-dilution flagged. Regulatory hurdles loom large.
8-K
Asset sale amendment closed
Charlie's Holdings closed an asset sale amendment on August 8, 2025, to R.J. Reynolds Vapor Company, offloading one more PMTA-covered synthetic product and related assets for $1.0 million at closing—now totaling sixteen items sold. This bolsters cash flow while streamlining the portfolio. Directors were elected at the August 7 annual meeting. Auditors ratified.
10-Q
Q1 FY2025 results
Charlie's Holdings saw product revenue drop 24.4% y/y to $2.3M in Q1 FY2025 ended March 31, 2025, mainly from softer nicotine vapor sales, yet operating loss narrowed 12.2% to $826K thanks to 21.5% lower expenses and cost controls like headcount cuts. Gross margin slipped to 22.9% from 30.9% on fixed cost pressures, while net loss widened 16.5% to $1.2M, driven by $149K debt extinguishment and higher interest, exceeding operating loss by over 20% due to those items. Cash dipped to $112K with $409K used in operations, but post-quarter asset sales to R.J. Reynolds for $6.5M cleared key debts and boosted liquidity. No non-GAAP metrics disclosed in the 10-Q. FDA regulatory hurdles loom large.
BTI
British American Tobacco Indus
57.29-0.45
CWBHF
Charlotte's Web Holdings Inc.
0.15+0.00
HCMC
Healthier Choices Management Co
0.00+0.00
KAVL
Kaival Brands Innovations Group
0.18+0.02
MO
Altria Group, Inc.
59.33+0.24
PM
Philip Morris International Inc
157.95-0.46
PYYX
Pyxus International, Inc.
3.10-0.10
RLX
RLX Technology Inc.
2.37-0.03
TOBAF
TAAT Global Alternatives Inc.
0.04+0.00
TPB
Turning Point Brands, Inc.
110.86+1.25